Market Closed -
Nyse
04:00:02 2025-02-14 pm EST
5-day change
1st Jan Change
112.26 USD
-0.55%
-5.55%
+0.58%
Capitalization
13.66B
13.01B
12.27B
10.83B
19.36B
1,184B
21.48B
146B
54.11B
495B
51.22B
50.18B
2,078B
P/E ratio 2024
50.7x
P/E ratio 2025 *
46.8x Enterprise value
15.62B
14.87B
14.03B
12.39B
22.13B
1,353B
24.56B
167B
61.88B
566B
58.57B
57.39B
2,376B
EV / Sales 2024
5.65x
EV / Sales 2025 *
5.43x Free-Float
99.71%
Yield 2024 *
0.25%
Yield 2025 *
0.24%
Timeframe
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Raymond James Adjusts Price Target on Revvity to $145 From $140
Feb. 03
MT
KeyBanc Adjusts Revvity Price Target to $145 From $132
Feb. 03
MT
Bernstein Adjusts Revvity Price Target to $140 From $130, Maintains Market Perform Rating
Feb. 03
MT
Citigroup Raises Price Target on Revvity to $155 From $145
Jan. 31
MT
Evercore ISI Adjusts Price Target on Revvity to $138 From $125
Jan. 31
MT
Revvity, Inc., Q4 2024 Earnings Call, Jan 31, 2025
Jan. 31
Revvity, Inc. Reports Earnings Results for the Fourth Quarter Ended December 29, 2024
Jan. 31
CI
Revvity Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Up Pre-Bell
Jan. 31
MT
Earnings Flash (RVTY) REVVITY Reports Q4 Revenue $729.4M, vs. FactSet Est of $727.9M
Jan. 31
MT
Earnings Flash (RVTY) REVVITY Reports Q4 Adjusted EPS $1.42, vs. FactSet Est of $1.37
Jan. 31
MT
Revvity, Inc. Provides Earnings Guidance for the Fiscal Year 2025
Jan. 31
CI
Tranche Update on Revvity, Inc.'s Equity Buyback Plan announced on November 4, 2024.
Jan. 30
CI
Baird Adjusts Revvity Price Target to $137 From $138, Maintains Outperform Rating
Jan. 27
MT
More news
Trois banques centrales (mais pas que)
24-07-29
En Direct des Marchés : TotalEnergies, LVMH, EssilorLuxottica, Emeis, Apple, 3M, Heineken, Mitsubishi...
24-07-29
RECOMENDACIONES DE LOS ANALISTAS EE.UU.: Alphabet, Meta Platforms, Amazon, Wise, Clorox...
24-02-02
USA-Les valeurs à suivre à Wall Street (actualisé)
23-10-30
MODERNA : un nouveau directeur financier
22-08-18
More news 1 day -0.55%
1 week -5.55%
Current month -11.00%
1 month -7.02%
3 months -3.27%
6 months -4.41%
Current year +0.58%
More quotes
Director
Title Age Since
Chief Executive Officer
60
2019-12-29
Director of Finance/CFO
36
2022-09-05
Chief Tech/Sci/R&D Officer
-
-
Manager
Title Age Since
Chairman
67
2019-12-29
Director/Board Member
73
2012-02-06
Director/Board Member
71
2016-07-26
More insiders
2024 2025 * Net sales
2.75B
2.62B
2.47B
2.18B
3.9B
239B
4.33B
29.44B
10.91B
99.74B
10.32B
10.11B
419B
2.83B
2.7B
2.54B
2.25B
4.01B
245B
4.45B
30.28B
11.22B
103B
10.62B
10.4B
431B
Net income
272M
259M
244M
215M
385M
23.54B
427M
2.91B
1.08B
9.84B
1.02B
998M
41.32B
278M
264M
249M
220M
393M
24.06B
437M
2.97B
1.1B
10.06B
1.04B
1.02B
42.23B
Net Debt
1.96B
1.87B
1.76B
1.55B
2.78B
170B
3.08B
20.96B
7.77B
71.02B
7.35B
7.2B
298B
1.73B
1.64B
1.55B
1.37B
2.45B
150B
2.72B
18.46B
6.84B
62.56B
6.47B
6.34B
263B
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows:
- medical diagnosis equipment (61%);
- analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc.
Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
More about the company
Date
Price
Change
Volume
25-02-14
112.26
$
-0.55%
793,480
25-02-13
112.88
$
+1.45%
770,070
25-02-12
111.27
$
-1.20%
926,044
25-02-11
112.62
$
-1.93%
1,159,226
25-02-10
114.84
$
-3.38%
1,394,174
Delayed Quote
Nyse, February 14, 2025 at 04:00 pm EST
More quotes
Last Close Price
112.26 USD
Average target price
141.19 USD
Spread / Average Target
+25.77%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1